Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Regulatory Effect of Cannabinoid Receptor Agonist on Chemokine-Induced Lymphocyte Chemotaxis
Takashi TanikawaKohta KurohaneYasuyuki Imai
ジャーナル フリー

2011 年 34 巻 7 号 p. 1090-1093


Cannabinoids elicit biological responses through two types of specific receptors, CB1 and CB2. Immune cells including naïve B-lymphocytes are known to selectively express peripheral cannabinoid receptors, CB2. Although the immunosuppressive effects of cannabinoids have become widely known, the mechanisms underlying their effects are not well understood. In this study, we demonstrated that splenic lymphocytes migrated toward a synthetic cannabinoid receptor agonist, WIN55,212-2. There is an optimal concentration range for induction of lymphocyte migration and a high dose fails to induce cell migration. Furthermore, a high dose of WIN55,212-2 significantly inhibited CXCL12-induced chemotaxis of lymphocytes. The inhibitory effect was transient and reversible. The inhibition was also observed when purified B-lymphocytes were used for CXCL12-induced chemotaxis. These results provide novel information regarding the cellular mechanisms underlying the effects of cannabinoids on the immune system.

© 2011 The Pharmaceutical Society of Japan
前の記事 次の記事